A Study of Baricitinib (LY3009104) in Participants With COVID-19
Clinical trial NCT04421027 · COMPLETED
Trial details
- NCT number
- NCT04421027
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2021-02-12
- Enrollment
- 1525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.